INFLUENCE OF PHYSICOCHEMICAL FACTORS ON THE SARS-COV-2 STRAIN ISOLATED FROM A DOG
Main Article Content
Authors
Abstract
This article presented the results of a study on the impact of physicochemical factors on the biological activity of the SARS-CoV-2 coronavirus isolated from a dog in the Republic of Kazakhstan. The results indicated that storing the virus at a temperature of -70°C led to a decrease in viral activity, similar to the effect observed when stored at room temperature. Storage at +40°C resulted in complete inactivation of the virus. The study on the effect of various concentrations of ionic and non-ionic detergents revealed that exposure to the ionic detergent DOC at concentrations of 0.1% and 0.5% caused a decrease in viral activity, while no change was observed at a concentration of 0.01%. The detergent SDS, at concentrations of 0.01%, 0.1%, and 0.5%, reduced the biological activity of the virus from the initial titer (5.25 lg TCID50/cm³) to 4.00 lg TCID50/cm³. Similarly, the use of non-ionic detergents, Triton X-100 and Tween-20, led to a reduction in viral activity from the initial titer to 4.50 lg TCID50/cm³.
The effect of pH in acidic, neutral, and alkaline environments on the biological activity of the virus was also studied. A decrease in viral activity was observed at acidic and alkaline pH levels, whereas a neutral pH environment had no impact on viral activity.
Keywords
coronavirus infection, physicochemical properties, biological activity.physico-chemical factors, isolation from the virus, virus resistance, coronavirus infection, virus resistance, biological activity
Article Details
References
Killerby ME, Biggs HM, Haynes A, Dahl RM, Mustaquim D, Gerber SI, et al. Human coronavirus circulation in the United States 2014-2017. J Clin Virol. 2018 Apr; 101: 52–6.
Al-Khannaq MN, Takebe Y, Pang YK, Oong XY, Tee KK, Ng KT, et al. Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia [Internet]. The American Journal of Tropical Medicine and Hygiene. 2016. 94: 1058–64. doi.org/10.4269/ajtmh.15-0810.
Fuentealba NA, More G, Bravi ME, et al. First detection and molecular analysis of SARS‐CoV‐2 from a naturally infected cat from Argentina. Vet Microbiol. 2021;260:109179. [PMC free article] [PubMed] [Google Scholar].
Bloom JD, Beichman AC, Neher RA, Harris K. Evolution of the SARS-CoV-2 mutational spectrum. bioRxiv [Preprint]. 2022 Nov 21:2022.11.19.517207. doi: 10.1101/2022.11.19.517207.
K. Zhugunissov, A. Kerimbayev, S. Kopeev, B. Myrzakhmetova, M. Tuyskanova, A. Nakhanov, B. Khairullin, M. Orynbayev, Ye. Abduraimov, M. Kassenov, K. Zakarya, L. Kutumbetov // SARS-CoV-2 virus: isolation, growth, thermostability, inactivation and passages. Experimental Biology. – 2022. - №1. – рр. 73-89. Crossref
Wurtz N., Penant G., Jardot P., Duclos N., Scola B.L. Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile // European Journal of Clinical Microbiology & Infectious Diseases. – 2021. – №40. – pp. 477-484. https://doi:10.1007/s10096-020-04106-0.
Reed L.J., Muench H.A. Simple Method of Estimating Fifty Per Cent Endpoints // The American Journal of Hygiene, – 1938. – №27 (3). – pр. 493-497.
Liebermann H., Tews G. Conditions for virus purification and concentration by means of differential centrifugation // Archiv fur experimentelle Veterinarmedizin. – 1982. -№ 36. рp. - 923-32.
Sabgayda T.P., Zubko A.V. Do cold temperatures affect the spread of the new coronavirus infection? Social'nye aspekty zdorov'a naselenia / Social aspects of population health [serial online] 2021; 67(1):1. (in russian)
Kasilingam D, Sathiya Prabhakaran SP, Rajendran DK, Rajagopal V, Santhosh Kumar T, Soundararaj A. Exploring the growth of COVID-19 cases using exponential modelling across 42 countries and predicting signs of early containment using machine learning. Transbound Emerg Dis. 2021 May;68(3):1001-1018. doi: 10.1111/tbed.13764.
Nurpeisova A, Khairullin B, Abitaev R, Shorayeva K, Jekebekov K, Kalimolda E, Kerimbayev A, Akylbayeva K, Abay Z, Myrzakhmetova B, Nakhanov A, Absatova Z, Nurabayev S, Orynbayev M, Assanzhanova N, Abeuov K, Kutumbetov L, Kassenov M, Abduraimov Y, Zakarya K. Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19. Hum Vaccin Immunother. 2022. 18(5):2087412. doi: 10.1080/21645515.2022.2087412
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L. Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters. Front Microbiol. 2021. 12:720437. doi: 10.3389/fmicb.2021.720437.
Khairullin B, Zakarya K, Orynbayev M, Abduraimov Y, Kassenov M, Sarsenbayeva G, Sultankulova K, Chervyakova O, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Zhugunissov K, Assanzhanova N, Nurabayev S, Kerimbayev A, Yershebulov Z, Burashev Y, Kulmagambetov I, Davlyatshin T, Sergeeva M, Buzitskaya Z, Stukova M, Kutumbetov L. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up. EClinicalMedicine. 2022. 50:101526. doi: 10.1016/j.eclinm.2022.101526.
Jekebekov KK, Nurpeisova AS, Abay ZS, Shorayeva KA, Absatova ZS, Abitayev RT, Kalimolda EZ, Moldagulova SU, Assanzhanova NN, Omurtay AD, Shayakhmetov YA, Sadikaliyeva SO, Barakbayev KB, Kassenov MM, Zakarya KD, Abduraimov YO. Safety Assessment: a Comparative Analysis of Quantitative Content of Bacterial Endotoxins and Evaluation of Pyrogenicity of the Kazakhstan Vaccine QazCovid-in® against COVID-19. Bull Exp Biol Med. 2024. 176(4):452-456. doi: 10.1007/s10517-024-06045-8.
Shorayeva K, Nakhanov A, Nurpeisova A, Chervyakova O, Jekebekov K, Abay Z, Assanzhanova N, Sadikaliyeva S, Kalimolda E, Terebay A, Moldagulova S, Absatova Z, Tulendibayev A, Kopeyev S, Nakhanova G, Issabek A, Nurabayev S, Kerimbayev A, Kutumbetov L, Abduraimov Y, Kassenov M, Orynbayev M, Zakarya K. Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19. Vaccines (Basel). 2023. 11(12):1771. doi: 10.3390/vaccines11121771.
Li, L., Li, X., Guo, Z., Wang, Z., Zhang, K., Li, C., Wang, C., & Zhang, S.. Influence of Storage Conditions on SARSCoV-2 Nucleic Acid Detection in Throat Swabs. // The Journal of infectious diseases 2020, vol.222(2). 203–205. doi.org/10.1093/infdis/jiaa272
Garrett A. Perchetti, Meei-Li Huang, Vikas Peddu, Keith R. Jerome, Alexander L. Greninger Stability of SARS-CoV-2 in Phosphate-Buffered Saline for Molecular Detection. // Journal of Clinical Microbiology 2020. vol. 58 (8) e01094-20; doi.org/10.1128/JCM.01094-20
Aboubakr, H. A., Sharafeldin, T. A., & Goyal, S. M.. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: A review. // Transboundary and emerging diseases.